Kingfa Science & Technology (India)（524019）株式概要Kingfa Science & Technology (India) Limited は、インドで強化ポリプロピレンコンパウンド、熱可塑性エラストマー、繊維強化複合材料、個人用保護具のマスクと手袋を製造・供給している。 詳細524019 ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長0/6過去の実績4/6財務の健全性6/6配当金0/6報酬過去1年間で収益は16.3%増加しました リスク分析リスクチェックの結果、524019 、リスクは検出されなかった。すべてのリスクチェックを見る524019 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value₹Current Price₹5.51k36.7% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture044b2016201920222025202620282031Revenue ₹44.0bEarnings ₹3.9bAdvancedSet Fair ValueView all narrativesKingfa Science & Technology (India) Limited 競合他社India GlycolsSymbol: BSE:500201Market cap: ₹68.0bEpigralSymbol: NSEI:EPIGRALMarket cap: ₹53.5bKAMA HoldingsSymbol: BSE:532468Market cap: ₹83.5bGulf Oil Lubricants IndiaSymbol: NSEI:GULFOILLUBMarket cap: ₹46.1b価格と性能株価の高値、安値、推移の概要Kingfa Science & Technology (India)過去の株価現在の株価₹5,514.0552週高値₹5,454.0052週安値₹3,016.05ベータ0.641ヶ月の変化12.09%3ヶ月変化22.62%1年変化61.53%3年間の変化175.05%5年間の変化512.13%IPOからの変化44,012.40%最新ニュースお知らせ • 22hKingfa Science & Technology (India) Limited to Report Q4, 2026 Results on May 29, 2026Kingfa Science & Technology (India) Limited announced that they will report Q4, 2026 results on May 29, 2026Reported Earnings • Feb 09Third quarter 2026 earnings released: EPS: ₹33.34 (vs ₹28.59 in 3Q 2025)Third quarter 2026 results: EPS: ₹33.34 (up from ₹28.59 in 3Q 2025). Revenue: ₹4.89b (up 11% from 3Q 2025). Net income: ₹451.7m (up 31% from 3Q 2025). Profit margin: 9.2% (up from 7.9% in 3Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has increased by 44% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Feb 02Kingfa Science & Technology (India) Limited to Report Q3, 2026 Results on Feb 07, 2026Kingfa Science & Technology (India) Limited announced that they will report Q3, 2026 results at 12:15 PM, Indian Standard Time on Feb 07, 2026Buy Or Sell Opportunity • Jan 29Now 20% overvaluedOver the last 90 days, the stock has fallen 8.4% to ₹4,242. The fair value is estimated to be ₹3,529, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 30%.Buy Or Sell Opportunity • Dec 22Now 20% overvaluedOver the last 90 days, the stock has fallen 1.8% to ₹4,294. The fair value is estimated to be ₹3,576, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 30%.Buy Or Sell Opportunity • Nov 27Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 4.4% to ₹4,361. The fair value is estimated to be ₹3,572, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 30%.最新情報をもっと見るRecent updatesお知らせ • 22hKingfa Science & Technology (India) Limited to Report Q4, 2026 Results on May 29, 2026Kingfa Science & Technology (India) Limited announced that they will report Q4, 2026 results on May 29, 2026Reported Earnings • Feb 09Third quarter 2026 earnings released: EPS: ₹33.34 (vs ₹28.59 in 3Q 2025)Third quarter 2026 results: EPS: ₹33.34 (up from ₹28.59 in 3Q 2025). Revenue: ₹4.89b (up 11% from 3Q 2025). Net income: ₹451.7m (up 31% from 3Q 2025). Profit margin: 9.2% (up from 7.9% in 3Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has increased by 44% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Feb 02Kingfa Science & Technology (India) Limited to Report Q3, 2026 Results on Feb 07, 2026Kingfa Science & Technology (India) Limited announced that they will report Q3, 2026 results at 12:15 PM, Indian Standard Time on Feb 07, 2026Buy Or Sell Opportunity • Jan 29Now 20% overvaluedOver the last 90 days, the stock has fallen 8.4% to ₹4,242. The fair value is estimated to be ₹3,529, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 30%.Buy Or Sell Opportunity • Dec 22Now 20% overvaluedOver the last 90 days, the stock has fallen 1.8% to ₹4,294. The fair value is estimated to be ₹3,576, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 30%.Buy Or Sell Opportunity • Nov 27Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 4.4% to ₹4,361. The fair value is estimated to be ₹3,572, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 30%.Reported Earnings • Nov 14Second quarter 2026 earnings released: EPS: ₹30.36 (vs ₹30.76 in 2Q 2025)Second quarter 2026 results: EPS: ₹30.36. Revenue: ₹4.68b (up 12% from 2Q 2025). Net income: ₹411.4m (up 10% from 2Q 2025). Profit margin: 8.8% (down from 8.9% in 2Q 2025). The decrease in margin was driven by higher expenses.お知らせ • Nov 07Kingfa Science & Technology (India) Limited to Report Q2, 2026 Results on Nov 12, 2025Kingfa Science & Technology (India) Limited announced that they will report Q2, 2026 results on Nov 12, 2025お知らせ • Sep 30Kingfa Science & Technology (India) Limited Approves Appointment of Subramanyan S. K. as A Non-Executive Independent DirectorKingfa Science & Technology (India) Limited announced that at the AGM held on September 29, 2025, approved appointment of Mr. Subramanyan S. K. (DIN:00024614) as a Non-Executive Independent Director.お知らせ • Sep 25Kingfa Science & Technology (India) Limited announced that it has received INR 4.9999924 billion in funding from Sanshi Fund - I, Custody Bank of Japan, Ltd. RE: RB Amundi Small Cap Equity Mother Fund, SBI Optimal Equity Fund - Long Term, SBI Funds Management LimitedOn September 24, 2025, Kingfa Science & Technology (India) Limited closed the transaction. The company issued 1,440,920 equity shares at an issue price of INR 3,470 for gross proceeds of INR 4,999,992,400. The transaction includes participation from new investors, Sanshi Fund - I for 72,046 shares and will acquire 0.53% stake, SBI Mutual Fund - SBI Flexicap Fund, a fund managed by SBI Funds Management Limited for 345,821 shares and will acquire 2.55% stake, SBI Funds Management Limited - SBI Automotive Opportunities Fund, a fund managed by SBI Funds Management Limited for 184,438 shares and will acquire 1.36% stake, SBI Conservative Hybrid Fund, a fund managed by SBI Funds Management Limited for 357,348 shares and will acquire 2.64% stake, Custody Bank of Japan, Ltd. RE: RB Amundi Small Cap Equity Mother Fund for 273,775 shares and will acquire 2.02% stake, SBI Optimal Equity Fund - Long Term for 100,864 shares and will acquire 0.74% stake and Sbi Emergent India Fund, a fund managed by SBI Funds Management Limited for 106,628 shares and will acquire 0.79% stake. The transaction has been approved by the board of directors.New Risk • Aug 27New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.お知らせ • Aug 25Kingfa Science & Technology (India) Limited, Annual General Meeting, Sep 29, 2025Kingfa Science & Technology (India) Limited, Annual General Meeting, Sep 29, 2025, at 11:30 Indian Standard Time.Valuation Update With 7 Day Price Move • Aug 18Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹4,149, the stock trades at a trailing P/E ratio of 32.7x. Average trailing P/E is 26x in the Chemicals industry in India. Total returns to shareholders of 327% over the past three years.Reported Earnings • Jul 31First quarter 2026 earnings released: EPS: ₹32.86 (vs ₹32.27 in 1Q 2025)First quarter 2026 results: EPS: ₹32.86 (up from ₹32.27 in 1Q 2025). Revenue: ₹4.66b (up 12% from 1Q 2025). Net income: ₹397.9m (up 1.8% from 1Q 2025). Profit margin: 8.5% (down from 9.4% in 1Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Jul 23Kingfa Science & Technology (India) Limited to Report Q1, 2026 Results on Jul 30, 2025Kingfa Science & Technology (India) Limited announced that they will report Q1, 2026 results on Jul 30, 2025Reported Earnings • May 29Full year 2025 earnings released: EPS: ₹126 (vs ₹101 in FY 2024)Full year 2025 results: EPS: ₹126 (up from ₹101 in FY 2024). Revenue: ₹17.5b (up 18% from FY 2024). Net income: ₹1.53b (up 25% from FY 2024). Profit margin: 8.7% (up from 8.2% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 47% per year whereas the company’s share price has increased by 52% per year.お知らせ • May 20Kingfa Science & Technology (India) Limited to Report Q4, 2025 Results on May 28, 2025Kingfa Science & Technology (India) Limited announced that they will report Q4, 2025 results on May 28, 2025お知らせ • Apr 01Kingfa Science & Technology (India) Limited Announces Resignation of Nirnoy Sur as Company Secretary & Compliance Officer, Effective March 31, 2025Kingfa Science & Technology (India) Limited informed that Mr. Nirnoy Sur has resigned as Company Secretary & Compliance Officer of the Company with effect from March 31,2025. Mr. Nirnoy Sur has tendered his resignation from the position of Company Secretary (Key Managerial Personnel), Compliance Officer and Nodal Officer of the Company vide letter dated February 11, 2025, due to his personal reasons and to pursue professional growth opportunities.Reported Earnings • Feb 13Third quarter 2025 earnings released: EPS: ₹28.59 (vs ₹20.09 in 3Q 2024)Third quarter 2025 results: EPS: ₹28.59 (up from ₹20.09 in 3Q 2024). Revenue: ₹4.40b (up 12% from 3Q 2024). Net income: ₹346.3m (up 42% from 3Q 2024). Profit margin: 7.9% (up from 6.2% in 3Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has only increased by 33% per year, which means it is significantly lagging earnings growth.お知らせ • Feb 11Kingfa Science & Technology (India) Limited Announces Resignation of Nirnoy Sur as Company Secretary, Effective March 31, 2025Kingfa Science & Technology (India) Limited approved Resignation of Mr. Nirnoy Sur as Company Secretary & Compliance Officer of the Company. Reason for Change: Resignation, due to his personal reasons and to pursue professional growth opportunities. Date of Cessation: March 31, 2025. Resignation letter date: February 11, 2025.お知らせ • Feb 03Kingfa Science & Technology (India) Limited to Report Q3, 2025 Results on Feb 11, 2025Kingfa Science & Technology (India) Limited announced that they will report Q3, 2025 results on Feb 11, 2025Valuation Update With 7 Day Price Move • Dec 03Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹3,324, the stock trades at a trailing P/E ratio of 30x. Average trailing P/E is 33x in the Chemicals industry in India. Total returns to shareholders of 259% over the past three years.Reported Earnings • Oct 30Second quarter 2025 earnings released: EPS: ₹30.76 (vs ₹24.44 in 2Q 2024)Second quarter 2025 results: EPS: ₹30.76 (up from ₹24.44 in 2Q 2024). Revenue: ₹4.19b (up 20% from 2Q 2024). Net income: ₹372.6m (up 26% from 2Q 2024). Profit margin: 8.9% (up from 8.4% in 2Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has only increased by 47% per year, which means it is significantly lagging earnings growth.お知らせ • Oct 21Kingfa Science & Technology (India) Limited to Report Q2, 2025 Results on Oct 29, 2024Kingfa Science & Technology (India) Limited announced that they will report Q2, 2025 results on Oct 29, 2024お知らせ • Sep 26Kingfa Science & Technology (India) Limited Approves Dividend for the Financial Year Ended March 31, 2024Kingfa Science & Technology (India) Limited at its AGM held on 25 September 2024 approved, Declaration of Dividend of INR 10/- per Equity Share of the face value of INR 10/- each (100%), of the Company for the financial year ended March 31, 2024.Upcoming Dividend • Sep 11Upcoming dividend of ₹10.00 per shareEligible shareholders must have bought the stock before 18 September 2024. Payment date: 24 October 2024. Trailing yield: 0.3%. Lower than top quartile of Indian dividend payers (1.0%). Lower than average of industry peers (0.6%).お知らせ • Aug 29Kingfa Science & Technology (India) Limited, Annual General Meeting, Sep 25, 2024Kingfa Science & Technology (India) Limited, Annual General Meeting, Sep 25, 2024, at 11:30 Indian Standard Time.New Risk • Aug 20New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 8.8% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (8.8% average weekly change). Minor Risk Paying a dividend despite having no free cash flows.Valuation Update With 7 Day Price Move • Aug 20Investor sentiment improves as stock rises 25%After last week's 25% share price gain to ₹3,557, the stock trades at a trailing P/E ratio of 34x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 232% over the past three years.お知らせ • Aug 09Kingfa Science & Technology (India) Limited Approves the Appointment of Mr. Ramachandran Sudhinder as an Independent DirectorKingfa Science & Technology (India) Limited approved the appointment of Mr. Ramachandran Sudhinder (DIN: 10628111) as an Independent Director.Reported Earnings • Aug 08First quarter 2025 earnings released: EPS: ₹32.26 (vs ₹28.93 in 1Q 2024)First quarter 2025 results: EPS: ₹32.26 (up from ₹28.93 in 1Q 2024). Revenue: ₹4.18b (up 24% from 1Q 2024). Net income: ₹390.7m (up 12% from 1Q 2024). Profit margin: 9.3% (down from 10% in 1Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has only increased by 32% per year, which means it is significantly lagging earnings growth.お知らせ • Jul 29Kingfa Science & Technology (India) Limited to Report Q1, 2025 Results on Aug 07, 2024Kingfa Science & Technology (India) Limited announced that they will report Q1, 2025 results on Aug 07, 2024Valuation Update With 7 Day Price Move • Jul 03Investor sentiment improves as stock rises 28%After last week's 28% share price gain to ₹2,589, the stock trades at a trailing P/E ratio of 25.6x. Average trailing P/E is 34x in the Chemicals industry in India. Total returns to shareholders of 117% over the past three years.Valuation Update With 7 Day Price Move • Jun 18Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹2,202, the stock trades at a trailing P/E ratio of 21.8x. Average trailing P/E is 33x in the Chemicals industry in India. Total returns to shareholders of 122% over the past three years.New Risk • Jun 04New minor risk - Dividend sustainabilityThe company has a short dividend paying track record. Less than a year of continuous dividend payments. Dividend yield: 0.5% This is considered a minor risk. For dividend focussed investors, companies that have not established a long-term track record of consistently maintaining or growing dividends are less attractive than those companies that have a long track record. Those that have a long track record have proven their underlying business is stable enough to consistently maintain or grow the dividend and that the company considers maintaining the dividend to be one of its priorities. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (23% accrual ratio). Minor Risk Short dividend paying track record (less than a year of continuous dividend payments).お知らせ • May 30Kingfa Science & Technology (India) Limited Recommends Dividend for the Financial Year 2023-24Kingfa Science & Technology (India) Limited recommended a final dividend of 100% i.e., INR 10/- (Rupees Ten Only) per equity share of Face Value of INR 10/- each, for the financial year 2023-24. The final dividend, if approved, by Shareholders in the upcoming AGM, will be paid/dispatched to the eligible shareholders on or before 30th day from the date of 40th Annual General Meeting.Reported Earnings • May 30Full year 2024 earnings released: EPS: ₹101 (vs ₹67.22 in FY 2023)Full year 2024 results: EPS: ₹101 (up from ₹67.22 in FY 2023). Revenue: ₹14.9b (up 6.2% from FY 2023). Net income: ₹1.23b (up 51% from FY 2023). Profit margin: 8.2% (up from 5.8% in FY 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 74% per year but the company’s share price has only increased by 25% per year, which means it is significantly lagging earnings growth.お知らせ • May 22Kingfa Science & Technology (India) Limited to Report Q4, 2024 Results on May 28, 2024Kingfa Science & Technology (India) Limited announced that they will report Q4, 2024 results on May 28, 2024お知らせ • May 16Kingfa Science & Technology (India) Limited Announces Cessation of N. Subramanian as an Independent DirectorKingfa Science & Technology (India) Limited informed that the Board of Directors in their meeting held on May 15, 2024, has considered and approved the following: Mr. N. Subramanian has completed his second term of 5 (Five) years as an Independent Director and consequently ceased to be a Director of the Company with effect from the close of business hours on May 15, 2024.Valuation Update With 7 Day Price Move • Mar 20Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₹1,825, the stock trades at a trailing P/E ratio of 17.6x. Average trailing P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 204% over the past three years.Reported Earnings • Feb 07Third quarter 2024 earnings released: EPS: ₹20.09 (vs ₹16.71 in 3Q 2023)Third quarter 2024 results: EPS: ₹20.09 (up from ₹16.71 in 3Q 2023). Revenue: ₹3.95b (up 16% from 3Q 2023). Net income: ₹243.3m (up 20% from 3Q 2023). Profit margin: 6.2% (up from 6.0% in 3Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 83% per year but the company’s share price has only increased by 49% per year, which means it is significantly lagging earnings growth.お知らせ • Jan 25Kingfa Science & Technology (India) Limited to Report Q3, 2024 Results on Feb 06, 2024Kingfa Science & Technology (India) Limited announced that they will report Q3, 2024 results on Feb 06, 2024Reported Earnings • Nov 10Second quarter 2024 earnings released: EPS: ₹24.44 (vs ₹18.24 in 2Q 2023)Second quarter 2024 results: EPS: ₹24.44 (up from ₹18.24 in 2Q 2023). Revenue: ₹3.51b (flat on 2Q 2023). Net income: ₹296.0m (up 34% from 2Q 2023). Profit margin: 8.4% (up from 6.3% in 2Q 2023). Over the last 3 years on average, earnings per share has increased by 86% per year but the company’s share price has only increased by 60% per year, which means it is significantly lagging earnings growth.お知らせ • Oct 28Kingfa Science & Technology (India) Limited to Report Q2, 2024 Results on Nov 07, 2023Kingfa Science & Technology (India) Limited announced that they will report Q2, 2024 results on Nov 07, 2023お知らせ • Aug 31Kingfa Science & Technology (India) Limited, Annual General Meeting, Sep 26, 2023Kingfa Science & Technology (India) Limited, Annual General Meeting, Sep 26, 2023, at 11:30 Indian Standard Time. Agenda: To consider Adoption of Audited Financial Statements of the Company for the Financial Year ended March 31, 2023; to consider re-appointment of Mr. Wu Xiaohui; to consider; to consider Approval for Payment of Commission to Independent Directors; to consider ratification of Remuneration to Cost Auditor and to consider such other matters.Reported Earnings • Aug 06First quarter 2024 earnings released: EPS: ₹28.93 (vs ₹2.04 in 1Q 2023)First quarter 2024 results: EPS: ₹28.93 (up from ₹2.04 in 1Q 2023). Revenue: ₹3.41b (down 1.4% from 1Q 2023). Net income: ₹350.4m (up ₹325.6m from 1Q 2023). Profit margin: 10% (up from 0.7% in 1Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 82% per year but the company’s share price has only increased by 64% per year, which means it is significantly lagging earnings growth.お知らせ • Jul 29Kingfa Science & Technology (India) Limited to Report Q1, 2024 Results on Aug 05, 2023Kingfa Science & Technology (India) Limited announced that they will report Q1, 2024 results on Aug 05, 2023Reported Earnings • May 30Full year 2023 earnings released: EPS: ₹67.22 (vs ₹25.29 in FY 2022)Full year 2023 results: EPS: ₹67.22 (up from ₹25.29 in FY 2022). Revenue: ₹14.1b (up 34% from FY 2022). Net income: ₹814.1m (up 166% from FY 2022). Profit margin: 5.8% (up from 2.9% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 61% per year but the company’s share price has increased by 67% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • May 25Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹2,037, the stock trades at a trailing P/E ratio of 50.6x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 373% over the past three years.Valuation Update With 7 Day Price Move • Apr 13Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹1,539, the stock trades at a trailing P/E ratio of 38.2x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 270% over the past three years.Reported Earnings • Feb 17Third quarter 2023 earnings released: EPS: ₹16.71 (vs ₹6.16 in 3Q 2022)Third quarter 2023 results: EPS: ₹16.71 (up from ₹6.16 in 3Q 2022). Revenue: ₹3.39b (up 32% from 3Q 2022). Net income: ₹202.3m (up 171% from 3Q 2022). Profit margin: 6.0% (up from 2.9% in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 28% per year and the company’s share price has also increased by 28% per year.Valuation Update With 7 Day Price Move • Feb 13Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹1,427, the stock trades at a trailing P/E ratio of 48x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 141% over the past three years.お知らせ • Feb 03Kingfa Science & Technology (India) Limited to Report Q3, 2023 Results on Feb 14, 2023Kingfa Science & Technology (India) Limited announced that they will report Q3, 2023 results on Feb 14, 2023Reported Earnings • Nov 16Second quarter 2023 earnings released: EPS: ₹18.24 (vs ₹6.15 in 2Q 2022)Second quarter 2023 results: EPS: ₹18.24 (up from ₹6.15 in 2Q 2022). Revenue: ₹3.51b (up 33% from 2Q 2022). Net income: ₹220.9m (up 197% from 2Q 2022). Profit margin: 6.3% (up from 2.8% in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has increased by 26% per year, which means it is tracking significantly ahead of earnings growth.Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Executive Director Doraiswami Balaji was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Nov 12Second quarter 2023 earnings released: EPS: ₹18.24 (vs ₹6.15 in 2Q 2022)Second quarter 2023 results: EPS: ₹18.24 (up from ₹6.15 in 2Q 2022). Revenue: ₹3.52b (up 33% from 2Q 2022). Net income: ₹220.9m (up 197% from 2Q 2022). Profit margin: 6.3% (up from 2.8% in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has increased by 31% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Nov 03Kingfa Science & Technology (India) Limited to Report Q2, 2023 Results on Nov 10, 2022Kingfa Science & Technology (India) Limited announced that they will report Q2, 2023 results on Nov 10, 2022Valuation Update With 7 Day Price Move • Nov 03Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹1,214, the stock trades at a trailing P/E ratio of 68.7x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 80% over the past three years.お知らせ • Aug 30Kingfa Science & Technology (India) Limited, Annual General Meeting, Sep 22, 2022Kingfa Science & Technology (India) Limited, Annual General Meeting, Sep 22, 2022, at 11:30 Indian Standard Time.Valuation Update With 7 Day Price Move • Aug 26Investor sentiment improved over the past weekAfter last week's 22% share price gain to ₹1,230, the stock trades at a trailing P/E ratio of 69.6x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 100% over the past three years.Reported Earnings • Aug 11First quarter 2023 earnings released: EPS: ₹2.04 (vs ₹9.68 in 1Q 2022)First quarter 2023 results: EPS: ₹2.04 (down from ₹9.68 in 1Q 2022). Revenue: ₹3.46b (up 56% from 1Q 2022). Net income: ₹24.7m (down 79% from 1Q 2022). Profit margin: 0.7% (down from 5.3% in 1Q 2022). Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 21% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Jun 27Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹896, the stock trades at a trailing P/E ratio of 35.4x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 34% over the past three years.Reported Earnings • May 29Full year 2022 earnings released: EPS: ₹25.29 (vs ₹4.39 in FY 2021)Full year 2022 results: EPS: ₹25.29 (up from ₹4.39 in FY 2021). Revenue: ₹10.5b (up 67% from FY 2021). Net income: ₹306.3m (up 476% from FY 2021). Profit margin: 2.9% (up from 0.8% in FY 2021). Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings.お知らせ • May 17Kingfa Science & Technology (India) Limited to Report Q4, 2022 Results on May 25, 2022Kingfa Science & Technology (India) Limited announced that they will report Q4, 2022 results on May 25, 2022Valuation Update With 7 Day Price Move • May 10Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₹955, the stock trades at a trailing P/E ratio of 40.9x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 60% over the past three years.Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Executive Director Doraiswami Balaji was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • Apr 05Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹1,375, the stock trades at a trailing P/E ratio of 58.9x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 107% over the past three years.Reported Earnings • Feb 13Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹6.16 (up from ₹1.36 in 3Q 2021). Revenue: ₹2.56b (up 32% from 3Q 2021). Net income: ₹74.6m (up 354% from 3Q 2021). Profit margin: 2.9% (up from 0.8% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has increased by 30% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Dec 29Investor sentiment improved over the past weekAfter last week's 24% share price gain to ₹1,352, the stock trades at a trailing P/E ratio of 73x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 71% over the past three years.Valuation Update With 7 Day Price Move • Dec 14Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹1,086, the stock trades at a trailing P/E ratio of 58.6x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 53% over the past three years.Board Change • Nov 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 1 highly experienced director. Executive Director Doraiswami Balaji was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Nov 01Second quarter 2022 earnings released: EPS ₹6.15 (vs ₹2.73 in 2Q 2021)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2022 results: Revenue: ₹2.65b (up 58% from 2Q 2021). Net income: ₹74.5m (up 126% from 2Q 2021). Profit margin: 2.8% (up from 2.0% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.お知らせ • Jun 18Kingfa Science & Technology (India) Limited Announces Closure of Operations at Jejuri Plant, PuneKingfa Science & Technology (India) Limited announced that its Board of Directors at their Meeting held on June 17, 2021 has decided to discontinue the operations carried out at its Jejuri Plant located at G 34, Addl. Jejuri Industrial Area, Jejuri, Tal. Purandar, Pune 412303 in view of the Commissioning of the Technically Advanced New Plant at Chakan located at Plot No: F 5/5, Chakan Industrial Area, Phase-2, MIDC, Village - Vasuli Shinde, Tal Khed, Pune 410501, as this will result in better control of its Operations.Reported Earnings • Feb 11Third quarter 2021 earnings released: EPS ₹1.36 (vs ₹6.29 in 3Q 2020)The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: ₹1.96b (up 3.8% from 3Q 2020). Net income: ₹16.5m (down 78% from 3Q 2020). Profit margin: 0.8% (down from 4.0% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 14% per year whereas the company’s share price has fallen by 16% per year.お知らせ • Feb 03Kingfa Science & Technology (India) Limited to Report Q3, 2021 Results on Feb 10, 2021Kingfa Science & Technology (India) Limited announced that they will report Q3, 2021 results on Feb 10, 2021Valuation Update With 7 Day Price Move • Jan 05Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹640, the stock is trading at a trailing P/E ratio of 75.2x, up from the previous P/E ratio of 64.6x. This compares to an average P/E of 18x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 22%.Is New 90 Day High Low • Jan 04New 90-day high: ₹639The company is up 28% from its price of ₹500 on 06 October 2020. The Indian market is up 20% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 22% over the same period.Valuation Update With 7 Day Price Move • Dec 15Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹621, the stock is trading at a trailing P/E ratio of 72.9x, up from the previous P/E ratio of 63.2x. This compares to an average P/E of 18x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 25%.Is New 90 Day High Low • Dec 15New 90-day high: ₹621The company is up 32% from its price of ₹470 on 16 September 2020. The Indian market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 13% over the same period.Reported Earnings • Nov 11Second quarter 2021 earnings released: EPS ₹2.73The company reported a poor second quarter result with weaker earnings, revenues and profit margins. Second quarter 2021 results: Revenue: ₹1.70b (down 11% from 2Q 2020). Net income: ₹33.0m (down 44% from 2Q 2020). Profit margin: 1.9% (down from 3.1% in 2Q 2020). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.お知らせ • Nov 01Kingfa Science & Technology (India) Limited to Report Q2, 2021 Results on Nov 10, 2020Kingfa Science & Technology (India) Limited announced that they will report Q2, 2021 results on Nov 10, 2020Is New 90 Day High Low • Oct 23New 90-day high: ₹597The company is up 34% from its price of ₹444 on 24 July 2020. The Indian market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 13% over the same period.Valuation Update With 7 Day Price Move • Oct 23Market bids up stock over the past weekAfter last week's 20% share price gain to ₹597, the stock is trading at a trailing P/E ratio of 56.2x, up from the previous P/E ratio of 47x. This compares to an average P/E of 15x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 20%.お知らせ • Jun 16Kingfa Science & Technology (India) Limited to Report Q4, 2020 Results on Jun 22, 2020Kingfa Science & Technology (India) Limited announced that they will report Q4, 2020 results on Jun 22, 2020株主還元524019IN ChemicalsIN 市場7D5.3%2.1%2.2%1Y61.5%-2.6%0.06%株主還元を見る業界別リターン: 524019過去 1 年間で-2.6 % の収益を上げたIndian Chemicals業界を上回りました。リターン対市場: 524019過去 1 年間で0.1 % の収益を上げたIndian市場を上回りました。価格変動Is 524019's price volatile compared to industry and market?524019 volatility524019 Average Weekly Movement5.2%Chemicals Industry Average Movement7.4%Market Average Movement7.2%10% most volatile stocks in IN Market10.3%10% least volatile stocks in IN Market4.8%安定した株価: 524019 、 Indian市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: 524019の 週次ボラティリティ ( 5% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト1983285Dazhong Wangwww.kingfaindia.comKingfa Science & Technology (India) Limited は、インドで強化ポリプロピレンコンパウンド、熱可塑性エラストマー、繊維強化複合材料、個人用保護具のマスクと手袋を製造・供給している。また、HYPRENEブランドの熱可塑性エラストマー、POMおよびLFT製品、グラスファイバーハニカム複合パネル、ポリプロピレン製品、PA6/PA66製品、エンジニアリングプラスチックコンパウンド、耐高温ナイロン/LCPも提供している。また、製品の輸出も行っている。旧社名はHydro S&S Industries Limitedで、2016年3月にKingfa Science & Technology (India) Limitedに社名変更した。同社は1983年に設立され、インドのプネーに拠点を置く。Kingfa Science & Technology (India) LimitedはM/s Kingfa Science & Technology Co Ltd中国の子会社である。もっと見るKingfa Science & Technology (India) Limited 基礎のまとめKingfa Science & Technology (India) の収益と売上を時価総額と比較するとどうか。524019 基礎統計学時価総額₹71.02b収益（TTM）₹1.68b売上高(TTM)₹18.87b44.5xPER（株価収益率4.0xP/Sレシオ524019 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計524019 損益計算書（TTM）収益₹18.87b売上原価₹14.51b売上総利益₹4.36bその他の費用₹2.68b収益₹1.68b直近の収益報告Dec 31, 2025次回決算日May 29, 2026一株当たり利益（EPS）123.98グロス・マージン23.11%純利益率8.91%有利子負債／自己資本比率1.4%524019 の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/26 15:09終値2026/05/26 00:00収益2025/12/31年間収益2025/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Kingfa Science & Technology (India) Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Kameswari V. S. ChavaliFirstCall Research
お知らせ • 22hKingfa Science & Technology (India) Limited to Report Q4, 2026 Results on May 29, 2026Kingfa Science & Technology (India) Limited announced that they will report Q4, 2026 results on May 29, 2026
Reported Earnings • Feb 09Third quarter 2026 earnings released: EPS: ₹33.34 (vs ₹28.59 in 3Q 2025)Third quarter 2026 results: EPS: ₹33.34 (up from ₹28.59 in 3Q 2025). Revenue: ₹4.89b (up 11% from 3Q 2025). Net income: ₹451.7m (up 31% from 3Q 2025). Profit margin: 9.2% (up from 7.9% in 3Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has increased by 44% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Feb 02Kingfa Science & Technology (India) Limited to Report Q3, 2026 Results on Feb 07, 2026Kingfa Science & Technology (India) Limited announced that they will report Q3, 2026 results at 12:15 PM, Indian Standard Time on Feb 07, 2026
Buy Or Sell Opportunity • Jan 29Now 20% overvaluedOver the last 90 days, the stock has fallen 8.4% to ₹4,242. The fair value is estimated to be ₹3,529, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 30%.
Buy Or Sell Opportunity • Dec 22Now 20% overvaluedOver the last 90 days, the stock has fallen 1.8% to ₹4,294. The fair value is estimated to be ₹3,576, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 30%.
Buy Or Sell Opportunity • Nov 27Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 4.4% to ₹4,361. The fair value is estimated to be ₹3,572, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 30%.
お知らせ • 22hKingfa Science & Technology (India) Limited to Report Q4, 2026 Results on May 29, 2026Kingfa Science & Technology (India) Limited announced that they will report Q4, 2026 results on May 29, 2026
Reported Earnings • Feb 09Third quarter 2026 earnings released: EPS: ₹33.34 (vs ₹28.59 in 3Q 2025)Third quarter 2026 results: EPS: ₹33.34 (up from ₹28.59 in 3Q 2025). Revenue: ₹4.89b (up 11% from 3Q 2025). Net income: ₹451.7m (up 31% from 3Q 2025). Profit margin: 9.2% (up from 7.9% in 3Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has increased by 44% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Feb 02Kingfa Science & Technology (India) Limited to Report Q3, 2026 Results on Feb 07, 2026Kingfa Science & Technology (India) Limited announced that they will report Q3, 2026 results at 12:15 PM, Indian Standard Time on Feb 07, 2026
Buy Or Sell Opportunity • Jan 29Now 20% overvaluedOver the last 90 days, the stock has fallen 8.4% to ₹4,242. The fair value is estimated to be ₹3,529, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 30%.
Buy Or Sell Opportunity • Dec 22Now 20% overvaluedOver the last 90 days, the stock has fallen 1.8% to ₹4,294. The fair value is estimated to be ₹3,576, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 30%.
Buy Or Sell Opportunity • Nov 27Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 4.4% to ₹4,361. The fair value is estimated to be ₹3,572, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 30%.
Reported Earnings • Nov 14Second quarter 2026 earnings released: EPS: ₹30.36 (vs ₹30.76 in 2Q 2025)Second quarter 2026 results: EPS: ₹30.36. Revenue: ₹4.68b (up 12% from 2Q 2025). Net income: ₹411.4m (up 10% from 2Q 2025). Profit margin: 8.8% (down from 8.9% in 2Q 2025). The decrease in margin was driven by higher expenses.
お知らせ • Nov 07Kingfa Science & Technology (India) Limited to Report Q2, 2026 Results on Nov 12, 2025Kingfa Science & Technology (India) Limited announced that they will report Q2, 2026 results on Nov 12, 2025
お知らせ • Sep 30Kingfa Science & Technology (India) Limited Approves Appointment of Subramanyan S. K. as A Non-Executive Independent DirectorKingfa Science & Technology (India) Limited announced that at the AGM held on September 29, 2025, approved appointment of Mr. Subramanyan S. K. (DIN:00024614) as a Non-Executive Independent Director.
お知らせ • Sep 25Kingfa Science & Technology (India) Limited announced that it has received INR 4.9999924 billion in funding from Sanshi Fund - I, Custody Bank of Japan, Ltd. RE: RB Amundi Small Cap Equity Mother Fund, SBI Optimal Equity Fund - Long Term, SBI Funds Management LimitedOn September 24, 2025, Kingfa Science & Technology (India) Limited closed the transaction. The company issued 1,440,920 equity shares at an issue price of INR 3,470 for gross proceeds of INR 4,999,992,400. The transaction includes participation from new investors, Sanshi Fund - I for 72,046 shares and will acquire 0.53% stake, SBI Mutual Fund - SBI Flexicap Fund, a fund managed by SBI Funds Management Limited for 345,821 shares and will acquire 2.55% stake, SBI Funds Management Limited - SBI Automotive Opportunities Fund, a fund managed by SBI Funds Management Limited for 184,438 shares and will acquire 1.36% stake, SBI Conservative Hybrid Fund, a fund managed by SBI Funds Management Limited for 357,348 shares and will acquire 2.64% stake, Custody Bank of Japan, Ltd. RE: RB Amundi Small Cap Equity Mother Fund for 273,775 shares and will acquire 2.02% stake, SBI Optimal Equity Fund - Long Term for 100,864 shares and will acquire 0.74% stake and Sbi Emergent India Fund, a fund managed by SBI Funds Management Limited for 106,628 shares and will acquire 0.79% stake. The transaction has been approved by the board of directors.
New Risk • Aug 27New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
お知らせ • Aug 25Kingfa Science & Technology (India) Limited, Annual General Meeting, Sep 29, 2025Kingfa Science & Technology (India) Limited, Annual General Meeting, Sep 29, 2025, at 11:30 Indian Standard Time.
Valuation Update With 7 Day Price Move • Aug 18Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹4,149, the stock trades at a trailing P/E ratio of 32.7x. Average trailing P/E is 26x in the Chemicals industry in India. Total returns to shareholders of 327% over the past three years.
Reported Earnings • Jul 31First quarter 2026 earnings released: EPS: ₹32.86 (vs ₹32.27 in 1Q 2025)First quarter 2026 results: EPS: ₹32.86 (up from ₹32.27 in 1Q 2025). Revenue: ₹4.66b (up 12% from 1Q 2025). Net income: ₹397.9m (up 1.8% from 1Q 2025). Profit margin: 8.5% (down from 9.4% in 1Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Jul 23Kingfa Science & Technology (India) Limited to Report Q1, 2026 Results on Jul 30, 2025Kingfa Science & Technology (India) Limited announced that they will report Q1, 2026 results on Jul 30, 2025
Reported Earnings • May 29Full year 2025 earnings released: EPS: ₹126 (vs ₹101 in FY 2024)Full year 2025 results: EPS: ₹126 (up from ₹101 in FY 2024). Revenue: ₹17.5b (up 18% from FY 2024). Net income: ₹1.53b (up 25% from FY 2024). Profit margin: 8.7% (up from 8.2% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 47% per year whereas the company’s share price has increased by 52% per year.
お知らせ • May 20Kingfa Science & Technology (India) Limited to Report Q4, 2025 Results on May 28, 2025Kingfa Science & Technology (India) Limited announced that they will report Q4, 2025 results on May 28, 2025
お知らせ • Apr 01Kingfa Science & Technology (India) Limited Announces Resignation of Nirnoy Sur as Company Secretary & Compliance Officer, Effective March 31, 2025Kingfa Science & Technology (India) Limited informed that Mr. Nirnoy Sur has resigned as Company Secretary & Compliance Officer of the Company with effect from March 31,2025. Mr. Nirnoy Sur has tendered his resignation from the position of Company Secretary (Key Managerial Personnel), Compliance Officer and Nodal Officer of the Company vide letter dated February 11, 2025, due to his personal reasons and to pursue professional growth opportunities.
Reported Earnings • Feb 13Third quarter 2025 earnings released: EPS: ₹28.59 (vs ₹20.09 in 3Q 2024)Third quarter 2025 results: EPS: ₹28.59 (up from ₹20.09 in 3Q 2024). Revenue: ₹4.40b (up 12% from 3Q 2024). Net income: ₹346.3m (up 42% from 3Q 2024). Profit margin: 7.9% (up from 6.2% in 3Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has only increased by 33% per year, which means it is significantly lagging earnings growth.
お知らせ • Feb 11Kingfa Science & Technology (India) Limited Announces Resignation of Nirnoy Sur as Company Secretary, Effective March 31, 2025Kingfa Science & Technology (India) Limited approved Resignation of Mr. Nirnoy Sur as Company Secretary & Compliance Officer of the Company. Reason for Change: Resignation, due to his personal reasons and to pursue professional growth opportunities. Date of Cessation: March 31, 2025. Resignation letter date: February 11, 2025.
お知らせ • Feb 03Kingfa Science & Technology (India) Limited to Report Q3, 2025 Results on Feb 11, 2025Kingfa Science & Technology (India) Limited announced that they will report Q3, 2025 results on Feb 11, 2025
Valuation Update With 7 Day Price Move • Dec 03Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹3,324, the stock trades at a trailing P/E ratio of 30x. Average trailing P/E is 33x in the Chemicals industry in India. Total returns to shareholders of 259% over the past three years.
Reported Earnings • Oct 30Second quarter 2025 earnings released: EPS: ₹30.76 (vs ₹24.44 in 2Q 2024)Second quarter 2025 results: EPS: ₹30.76 (up from ₹24.44 in 2Q 2024). Revenue: ₹4.19b (up 20% from 2Q 2024). Net income: ₹372.6m (up 26% from 2Q 2024). Profit margin: 8.9% (up from 8.4% in 2Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has only increased by 47% per year, which means it is significantly lagging earnings growth.
お知らせ • Oct 21Kingfa Science & Technology (India) Limited to Report Q2, 2025 Results on Oct 29, 2024Kingfa Science & Technology (India) Limited announced that they will report Q2, 2025 results on Oct 29, 2024
お知らせ • Sep 26Kingfa Science & Technology (India) Limited Approves Dividend for the Financial Year Ended March 31, 2024Kingfa Science & Technology (India) Limited at its AGM held on 25 September 2024 approved, Declaration of Dividend of INR 10/- per Equity Share of the face value of INR 10/- each (100%), of the Company for the financial year ended March 31, 2024.
Upcoming Dividend • Sep 11Upcoming dividend of ₹10.00 per shareEligible shareholders must have bought the stock before 18 September 2024. Payment date: 24 October 2024. Trailing yield: 0.3%. Lower than top quartile of Indian dividend payers (1.0%). Lower than average of industry peers (0.6%).
お知らせ • Aug 29Kingfa Science & Technology (India) Limited, Annual General Meeting, Sep 25, 2024Kingfa Science & Technology (India) Limited, Annual General Meeting, Sep 25, 2024, at 11:30 Indian Standard Time.
New Risk • Aug 20New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 8.8% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (8.8% average weekly change). Minor Risk Paying a dividend despite having no free cash flows.
Valuation Update With 7 Day Price Move • Aug 20Investor sentiment improves as stock rises 25%After last week's 25% share price gain to ₹3,557, the stock trades at a trailing P/E ratio of 34x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 232% over the past three years.
お知らせ • Aug 09Kingfa Science & Technology (India) Limited Approves the Appointment of Mr. Ramachandran Sudhinder as an Independent DirectorKingfa Science & Technology (India) Limited approved the appointment of Mr. Ramachandran Sudhinder (DIN: 10628111) as an Independent Director.
Reported Earnings • Aug 08First quarter 2025 earnings released: EPS: ₹32.26 (vs ₹28.93 in 1Q 2024)First quarter 2025 results: EPS: ₹32.26 (up from ₹28.93 in 1Q 2024). Revenue: ₹4.18b (up 24% from 1Q 2024). Net income: ₹390.7m (up 12% from 1Q 2024). Profit margin: 9.3% (down from 10% in 1Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has only increased by 32% per year, which means it is significantly lagging earnings growth.
お知らせ • Jul 29Kingfa Science & Technology (India) Limited to Report Q1, 2025 Results on Aug 07, 2024Kingfa Science & Technology (India) Limited announced that they will report Q1, 2025 results on Aug 07, 2024
Valuation Update With 7 Day Price Move • Jul 03Investor sentiment improves as stock rises 28%After last week's 28% share price gain to ₹2,589, the stock trades at a trailing P/E ratio of 25.6x. Average trailing P/E is 34x in the Chemicals industry in India. Total returns to shareholders of 117% over the past three years.
Valuation Update With 7 Day Price Move • Jun 18Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹2,202, the stock trades at a trailing P/E ratio of 21.8x. Average trailing P/E is 33x in the Chemicals industry in India. Total returns to shareholders of 122% over the past three years.
New Risk • Jun 04New minor risk - Dividend sustainabilityThe company has a short dividend paying track record. Less than a year of continuous dividend payments. Dividend yield: 0.5% This is considered a minor risk. For dividend focussed investors, companies that have not established a long-term track record of consistently maintaining or growing dividends are less attractive than those companies that have a long track record. Those that have a long track record have proven their underlying business is stable enough to consistently maintain or grow the dividend and that the company considers maintaining the dividend to be one of its priorities. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (23% accrual ratio). Minor Risk Short dividend paying track record (less than a year of continuous dividend payments).
お知らせ • May 30Kingfa Science & Technology (India) Limited Recommends Dividend for the Financial Year 2023-24Kingfa Science & Technology (India) Limited recommended a final dividend of 100% i.e., INR 10/- (Rupees Ten Only) per equity share of Face Value of INR 10/- each, for the financial year 2023-24. The final dividend, if approved, by Shareholders in the upcoming AGM, will be paid/dispatched to the eligible shareholders on or before 30th day from the date of 40th Annual General Meeting.
Reported Earnings • May 30Full year 2024 earnings released: EPS: ₹101 (vs ₹67.22 in FY 2023)Full year 2024 results: EPS: ₹101 (up from ₹67.22 in FY 2023). Revenue: ₹14.9b (up 6.2% from FY 2023). Net income: ₹1.23b (up 51% from FY 2023). Profit margin: 8.2% (up from 5.8% in FY 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 74% per year but the company’s share price has only increased by 25% per year, which means it is significantly lagging earnings growth.
お知らせ • May 22Kingfa Science & Technology (India) Limited to Report Q4, 2024 Results on May 28, 2024Kingfa Science & Technology (India) Limited announced that they will report Q4, 2024 results on May 28, 2024
お知らせ • May 16Kingfa Science & Technology (India) Limited Announces Cessation of N. Subramanian as an Independent DirectorKingfa Science & Technology (India) Limited informed that the Board of Directors in their meeting held on May 15, 2024, has considered and approved the following: Mr. N. Subramanian has completed his second term of 5 (Five) years as an Independent Director and consequently ceased to be a Director of the Company with effect from the close of business hours on May 15, 2024.
Valuation Update With 7 Day Price Move • Mar 20Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₹1,825, the stock trades at a trailing P/E ratio of 17.6x. Average trailing P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 204% over the past three years.
Reported Earnings • Feb 07Third quarter 2024 earnings released: EPS: ₹20.09 (vs ₹16.71 in 3Q 2023)Third quarter 2024 results: EPS: ₹20.09 (up from ₹16.71 in 3Q 2023). Revenue: ₹3.95b (up 16% from 3Q 2023). Net income: ₹243.3m (up 20% from 3Q 2023). Profit margin: 6.2% (up from 6.0% in 3Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 83% per year but the company’s share price has only increased by 49% per year, which means it is significantly lagging earnings growth.
お知らせ • Jan 25Kingfa Science & Technology (India) Limited to Report Q3, 2024 Results on Feb 06, 2024Kingfa Science & Technology (India) Limited announced that they will report Q3, 2024 results on Feb 06, 2024
Reported Earnings • Nov 10Second quarter 2024 earnings released: EPS: ₹24.44 (vs ₹18.24 in 2Q 2023)Second quarter 2024 results: EPS: ₹24.44 (up from ₹18.24 in 2Q 2023). Revenue: ₹3.51b (flat on 2Q 2023). Net income: ₹296.0m (up 34% from 2Q 2023). Profit margin: 8.4% (up from 6.3% in 2Q 2023). Over the last 3 years on average, earnings per share has increased by 86% per year but the company’s share price has only increased by 60% per year, which means it is significantly lagging earnings growth.
お知らせ • Oct 28Kingfa Science & Technology (India) Limited to Report Q2, 2024 Results on Nov 07, 2023Kingfa Science & Technology (India) Limited announced that they will report Q2, 2024 results on Nov 07, 2023
お知らせ • Aug 31Kingfa Science & Technology (India) Limited, Annual General Meeting, Sep 26, 2023Kingfa Science & Technology (India) Limited, Annual General Meeting, Sep 26, 2023, at 11:30 Indian Standard Time. Agenda: To consider Adoption of Audited Financial Statements of the Company for the Financial Year ended March 31, 2023; to consider re-appointment of Mr. Wu Xiaohui; to consider; to consider Approval for Payment of Commission to Independent Directors; to consider ratification of Remuneration to Cost Auditor and to consider such other matters.
Reported Earnings • Aug 06First quarter 2024 earnings released: EPS: ₹28.93 (vs ₹2.04 in 1Q 2023)First quarter 2024 results: EPS: ₹28.93 (up from ₹2.04 in 1Q 2023). Revenue: ₹3.41b (down 1.4% from 1Q 2023). Net income: ₹350.4m (up ₹325.6m from 1Q 2023). Profit margin: 10% (up from 0.7% in 1Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 82% per year but the company’s share price has only increased by 64% per year, which means it is significantly lagging earnings growth.
お知らせ • Jul 29Kingfa Science & Technology (India) Limited to Report Q1, 2024 Results on Aug 05, 2023Kingfa Science & Technology (India) Limited announced that they will report Q1, 2024 results on Aug 05, 2023
Reported Earnings • May 30Full year 2023 earnings released: EPS: ₹67.22 (vs ₹25.29 in FY 2022)Full year 2023 results: EPS: ₹67.22 (up from ₹25.29 in FY 2022). Revenue: ₹14.1b (up 34% from FY 2022). Net income: ₹814.1m (up 166% from FY 2022). Profit margin: 5.8% (up from 2.9% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 61% per year but the company’s share price has increased by 67% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • May 25Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹2,037, the stock trades at a trailing P/E ratio of 50.6x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 373% over the past three years.
Valuation Update With 7 Day Price Move • Apr 13Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹1,539, the stock trades at a trailing P/E ratio of 38.2x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 270% over the past three years.
Reported Earnings • Feb 17Third quarter 2023 earnings released: EPS: ₹16.71 (vs ₹6.16 in 3Q 2022)Third quarter 2023 results: EPS: ₹16.71 (up from ₹6.16 in 3Q 2022). Revenue: ₹3.39b (up 32% from 3Q 2022). Net income: ₹202.3m (up 171% from 3Q 2022). Profit margin: 6.0% (up from 2.9% in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 28% per year and the company’s share price has also increased by 28% per year.
Valuation Update With 7 Day Price Move • Feb 13Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹1,427, the stock trades at a trailing P/E ratio of 48x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 141% over the past three years.
お知らせ • Feb 03Kingfa Science & Technology (India) Limited to Report Q3, 2023 Results on Feb 14, 2023Kingfa Science & Technology (India) Limited announced that they will report Q3, 2023 results on Feb 14, 2023
Reported Earnings • Nov 16Second quarter 2023 earnings released: EPS: ₹18.24 (vs ₹6.15 in 2Q 2022)Second quarter 2023 results: EPS: ₹18.24 (up from ₹6.15 in 2Q 2022). Revenue: ₹3.51b (up 33% from 2Q 2022). Net income: ₹220.9m (up 197% from 2Q 2022). Profit margin: 6.3% (up from 2.8% in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has increased by 26% per year, which means it is tracking significantly ahead of earnings growth.
Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Executive Director Doraiswami Balaji was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Nov 12Second quarter 2023 earnings released: EPS: ₹18.24 (vs ₹6.15 in 2Q 2022)Second quarter 2023 results: EPS: ₹18.24 (up from ₹6.15 in 2Q 2022). Revenue: ₹3.52b (up 33% from 2Q 2022). Net income: ₹220.9m (up 197% from 2Q 2022). Profit margin: 6.3% (up from 2.8% in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has increased by 31% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Nov 03Kingfa Science & Technology (India) Limited to Report Q2, 2023 Results on Nov 10, 2022Kingfa Science & Technology (India) Limited announced that they will report Q2, 2023 results on Nov 10, 2022
Valuation Update With 7 Day Price Move • Nov 03Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹1,214, the stock trades at a trailing P/E ratio of 68.7x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 80% over the past three years.
お知らせ • Aug 30Kingfa Science & Technology (India) Limited, Annual General Meeting, Sep 22, 2022Kingfa Science & Technology (India) Limited, Annual General Meeting, Sep 22, 2022, at 11:30 Indian Standard Time.
Valuation Update With 7 Day Price Move • Aug 26Investor sentiment improved over the past weekAfter last week's 22% share price gain to ₹1,230, the stock trades at a trailing P/E ratio of 69.6x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 100% over the past three years.
Reported Earnings • Aug 11First quarter 2023 earnings released: EPS: ₹2.04 (vs ₹9.68 in 1Q 2022)First quarter 2023 results: EPS: ₹2.04 (down from ₹9.68 in 1Q 2022). Revenue: ₹3.46b (up 56% from 1Q 2022). Net income: ₹24.7m (down 79% from 1Q 2022). Profit margin: 0.7% (down from 5.3% in 1Q 2022). Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 21% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Jun 27Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹896, the stock trades at a trailing P/E ratio of 35.4x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 34% over the past three years.
Reported Earnings • May 29Full year 2022 earnings released: EPS: ₹25.29 (vs ₹4.39 in FY 2021)Full year 2022 results: EPS: ₹25.29 (up from ₹4.39 in FY 2021). Revenue: ₹10.5b (up 67% from FY 2021). Net income: ₹306.3m (up 476% from FY 2021). Profit margin: 2.9% (up from 0.8% in FY 2021). Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings.
お知らせ • May 17Kingfa Science & Technology (India) Limited to Report Q4, 2022 Results on May 25, 2022Kingfa Science & Technology (India) Limited announced that they will report Q4, 2022 results on May 25, 2022
Valuation Update With 7 Day Price Move • May 10Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₹955, the stock trades at a trailing P/E ratio of 40.9x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 60% over the past three years.
Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Executive Director Doraiswami Balaji was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • Apr 05Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹1,375, the stock trades at a trailing P/E ratio of 58.9x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 107% over the past three years.
Reported Earnings • Feb 13Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹6.16 (up from ₹1.36 in 3Q 2021). Revenue: ₹2.56b (up 32% from 3Q 2021). Net income: ₹74.6m (up 354% from 3Q 2021). Profit margin: 2.9% (up from 0.8% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has increased by 30% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Dec 29Investor sentiment improved over the past weekAfter last week's 24% share price gain to ₹1,352, the stock trades at a trailing P/E ratio of 73x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 71% over the past three years.
Valuation Update With 7 Day Price Move • Dec 14Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹1,086, the stock trades at a trailing P/E ratio of 58.6x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 53% over the past three years.
Board Change • Nov 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 1 highly experienced director. Executive Director Doraiswami Balaji was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Nov 01Second quarter 2022 earnings released: EPS ₹6.15 (vs ₹2.73 in 2Q 2021)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2022 results: Revenue: ₹2.65b (up 58% from 2Q 2021). Net income: ₹74.5m (up 126% from 2Q 2021). Profit margin: 2.8% (up from 2.0% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.
お知らせ • Jun 18Kingfa Science & Technology (India) Limited Announces Closure of Operations at Jejuri Plant, PuneKingfa Science & Technology (India) Limited announced that its Board of Directors at their Meeting held on June 17, 2021 has decided to discontinue the operations carried out at its Jejuri Plant located at G 34, Addl. Jejuri Industrial Area, Jejuri, Tal. Purandar, Pune 412303 in view of the Commissioning of the Technically Advanced New Plant at Chakan located at Plot No: F 5/5, Chakan Industrial Area, Phase-2, MIDC, Village - Vasuli Shinde, Tal Khed, Pune 410501, as this will result in better control of its Operations.
Reported Earnings • Feb 11Third quarter 2021 earnings released: EPS ₹1.36 (vs ₹6.29 in 3Q 2020)The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: ₹1.96b (up 3.8% from 3Q 2020). Net income: ₹16.5m (down 78% from 3Q 2020). Profit margin: 0.8% (down from 4.0% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 14% per year whereas the company’s share price has fallen by 16% per year.
お知らせ • Feb 03Kingfa Science & Technology (India) Limited to Report Q3, 2021 Results on Feb 10, 2021Kingfa Science & Technology (India) Limited announced that they will report Q3, 2021 results on Feb 10, 2021
Valuation Update With 7 Day Price Move • Jan 05Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹640, the stock is trading at a trailing P/E ratio of 75.2x, up from the previous P/E ratio of 64.6x. This compares to an average P/E of 18x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 22%.
Is New 90 Day High Low • Jan 04New 90-day high: ₹639The company is up 28% from its price of ₹500 on 06 October 2020. The Indian market is up 20% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 22% over the same period.
Valuation Update With 7 Day Price Move • Dec 15Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹621, the stock is trading at a trailing P/E ratio of 72.9x, up from the previous P/E ratio of 63.2x. This compares to an average P/E of 18x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 25%.
Is New 90 Day High Low • Dec 15New 90-day high: ₹621The company is up 32% from its price of ₹470 on 16 September 2020. The Indian market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 13% over the same period.
Reported Earnings • Nov 11Second quarter 2021 earnings released: EPS ₹2.73The company reported a poor second quarter result with weaker earnings, revenues and profit margins. Second quarter 2021 results: Revenue: ₹1.70b (down 11% from 2Q 2020). Net income: ₹33.0m (down 44% from 2Q 2020). Profit margin: 1.9% (down from 3.1% in 2Q 2020). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.
お知らせ • Nov 01Kingfa Science & Technology (India) Limited to Report Q2, 2021 Results on Nov 10, 2020Kingfa Science & Technology (India) Limited announced that they will report Q2, 2021 results on Nov 10, 2020
Is New 90 Day High Low • Oct 23New 90-day high: ₹597The company is up 34% from its price of ₹444 on 24 July 2020. The Indian market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 13% over the same period.
Valuation Update With 7 Day Price Move • Oct 23Market bids up stock over the past weekAfter last week's 20% share price gain to ₹597, the stock is trading at a trailing P/E ratio of 56.2x, up from the previous P/E ratio of 47x. This compares to an average P/E of 15x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 20%.
お知らせ • Jun 16Kingfa Science & Technology (India) Limited to Report Q4, 2020 Results on Jun 22, 2020Kingfa Science & Technology (India) Limited announced that they will report Q4, 2020 results on Jun 22, 2020
